Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment (Q33599831)

28 July 2017

title

Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment (English)

1 reference

28 July 2017

0 references

0 references

1 reference

cognitive dysfunction

1 reference

Pavel Gurevich

1

1 reference

28 July 2017

Hannes Stuke

2

1 reference

28 July 2017

Andreas Kastrup

3

1 reference

28 July 2017

Heiner Stuke

4

1 reference

28 July 2017

Helmut Hildebrandt

5

1 reference

28 July 2017

language of work or name

1 reference

25 April 2017

1 reference

Frontiers in Aging Neuroscience

28 July 2017

published in

1 reference

28 July 2017

volume

9

1 reference

28 July 2017

page(s)

114

1 reference

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

A Comparison of Magnetic Resonance Imaging and Neuropsychological Examination in the Diagnostic Distinction of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Why significant variables aren't automatically good predictors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Memory profiles in pathology or biomarker confirmed Alzheimer disease and frontotemporal dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Cognitive profiles of patients with mild cognitive impairment or dementia in Alzheimer's or Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Neuropsychological assessment of patients with dementing illness

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Multimodal classification of Alzheimer's disease and mild cognitive impairment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Comparing predictors of conversion and decline in mild cognitive impairment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Automatic classification of MR scans in Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Conceptual fluency at test shifts recognition response bias in Alzheimer's disease: implications for increased false recognition

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5403832

Free Recall Episodic Memory Performance Predicts Dementia Ten Years prior to Clinical Diagnosis: Findings from the Betula Longitudinal Study.

28 July 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Associative recognition in Alzheimer's disease: evidence for impaired recall-to-reject

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Correlation between Cognitive Impairment and CSF Biomarkers in Amnesic MCI, non-Amnesic MCI, and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

False recognition helps to distinguish patients with Alzheimer's disease and amnestic MCI from patients with other kinds of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Word-finding difficulty: a clinical analysis of the progressive aphasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2017.00114

21 January 2018

Identifiers

DOI

10.3389/FNAGI.2017.00114

1 reference

28 July 2017

1 reference

28 July 2017

1 reference